Who needs an artificial pancreas?

Journal of Diabetes

Volumn 5, Issue 3, 2013, Pages 254-257

  Winikoff, Janet ^a   Drexler, Andrew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Artificial pancreas; Closed loop system; Diabetes management; Insulin delivery

Indexed keywords

CARBOHYDRATE; GLUCAGON; GLUCOSE; INCRETIN; INSULIN; PRAMLINTIDE;

ARTIFICIAL PANCREAS; DIET RESTRICTION; EXERCISE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN RESPONSE; MEAL; PRIORITY JOURNAL; REVIEW; SEDENTARY LIFESTYLE;

ARTIFICIAL PANCREAS; CLOSED LOOP SYSTEM; DIABETES MANAGEMENT; INSULIN DELIVERY;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; PANCREAS, ARTIFICIAL;

EID: 84881553093     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12052     Document Type: Review

References (10)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986.
2. Cobelli C, Renard E, Kovatchev B. Artificial pancreas: Past, present, future. Diabetes. 2011; 60: 2672-2682.
3. Kovatchev B, Cobelli C, Renard E etal. Multinational study of subcutaneous model-predictive closed-loop control in type i diabetes mellitus: Summary of the results. Diabetes. 2010; 4: 1374-1381.
4. Castle JR, Pitts A, Hanavan K etal. The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes. Diabetes Care. 2012; 35: 706-710.
5. Nauck M, Stockman F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986; 29: 46-52. (Abstract).
6. Radziuk J. The artificial pancreas. Diabetes. 2012; 61: 2221-2224.
7. Eleri D, Allen JM, Kumareswaran K etal. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes. Diabetes Care. 2012; 35: 2182-2187.
8. Dassau E, Zisser H, Harvey RA etal. Clinical evaluation of a personalized artificial pancreas. Diabetes Care. 2013; 36: 801-809.
9. Weinzimer S, Sherr JL, Cengiz E etal. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care. 2012; 35: 1994-1999.
10. Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care. 2012; 35: 2148-2155.